Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs duloxetine for chemotherapy-induced peripheral neuropathy
IRCT20211028052893N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Melatonin with Duloxetine (2 arms). Started Sep 2024; status: completed.
02
Drugs
melatoninduloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20211028052893N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211028052893N1.